LU73386A1 - - Google Patents

Info

Publication number
LU73386A1
LU73386A1 LU73386A LU73386A LU73386A1 LU 73386 A1 LU73386 A1 LU 73386A1 LU 73386 A LU73386 A LU 73386A LU 73386 A LU73386 A LU 73386A LU 73386 A1 LU73386 A1 LU 73386A1
Authority
LU
Luxembourg
Application number
LU73386A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73386A1 publication Critical patent/LU73386A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU73386A 1974-09-12 1975-09-12 LU73386A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US505344A US3929758A (en) 1974-09-12 1974-09-12 Cyclization of cysteine-containing peptides

Publications (1)

Publication Number Publication Date
LU73386A1 true LU73386A1 (xx) 1976-04-13

Family

ID=24009941

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73386A LU73386A1 (xx) 1974-09-12 1975-09-12

Country Status (16)

Country Link
US (1) US3929758A (xx)
JP (1) JPS5833864B2 (xx)
AU (1) AU498757B2 (xx)
BE (1) BE833336A (xx)
CA (1) CA1045117A (xx)
DE (1) DE2540780A1 (xx)
DK (1) DK409775A (xx)
ES (1) ES440922A1 (xx)
FR (1) FR2284591A1 (xx)
GB (1) GB1527252A (xx)
HU (1) HU175202B (xx)
IT (1) IT1042496B (xx)
LU (1) LU73386A1 (xx)
NL (1) NL179909C (xx)
SU (1) SU849998A3 (xx)
YU (1) YU39747B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4066634A (en) * 1976-08-31 1978-01-03 American Home Products Corporation Purification of synthetic somatostatin
US4304692A (en) * 1978-07-24 1981-12-08 Armour Pharmaceutical Company Synthesis of biologically active peptides
US4212795A (en) * 1978-11-13 1980-07-15 Armour Pharmaceutical Company Cyclization of peptides
US4388235A (en) * 1982-02-12 1983-06-14 Armour Pharmaceutical Company Synthesis of peptides
US4401593A (en) * 1982-02-12 1983-08-30 Armour Pharmaceutical Company Glycine - 8 calcitonin
US4397780A (en) * 1982-02-12 1983-08-09 Armour Pharmaceutical Company Leucine22 -calcitonin
US4391747A (en) * 1982-02-12 1983-07-05 Armour Pharmaceutical Company Des asparagine-3-calcitonin
US4444681A (en) * 1982-09-24 1984-04-24 Armour Pharmaceutical Company L-Tyrosine21 calcitonin
US4469632A (en) * 1982-09-24 1984-09-04 Armour Pharmaceutical Company D-Arginine24 calcitonin
US4451395A (en) * 1982-11-08 1984-05-29 Armour Pharmaceutical Company Des-serine2 -des-tyrosine22 calcitonin
JPS60500054A (ja) * 1983-02-15 1985-01-17 ア−マ−・フア−マシユ−テイカル・カンパニ− デス−アスパラギン−３−カルシトニン
JPS60500055A (ja) * 1983-02-15 1985-01-17 ア−マ−・ファ−マシュ−ティカル・カンパニ− グリシン−８−カルシトニン
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US4623716A (en) * 1984-11-01 1986-11-18 Usv Pharmaceutical Corp. Process for the preparation and purification of peptides
JPH0517511Y2 (xx) * 1985-09-30 1993-05-11
US4644054A (en) * 1985-10-01 1987-02-17 Kempe Tomas G Calcitonin analogs with amino acid substituents at position 31
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
US4687839A (en) * 1985-12-23 1987-08-18 Kempe Tomas G Calcitonin gene related peptide analogs with C-terminal D-amino acid substituents
US4697002A (en) * 1985-12-23 1987-09-29 Kempe Tomas G Calcitonin gene related peptide analogs with amino acid subdstituents at the penultimate position 36
US4820804A (en) * 1987-04-21 1989-04-11 Rorer Pharmaceutical Corporation Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
US4824936A (en) * 1987-05-06 1989-04-25 Rorer Pharmaceutical Corporation (19-Alanine) calcitonin
JP2682061B2 (ja) * 1988-10-07 1997-11-26 藤沢薬品工業株式会社 ペプチドの分子内ジスルフィド結合の形成法
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
ATE193892T1 (de) * 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
PL176317B1 (pl) * 1993-06-29 1999-05-31 Ferring Bv Wodny preparat do donosowego stosowania desmopresyny
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
EP1452868A2 (en) * 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
US7723474B2 (en) * 2003-10-21 2010-05-25 The Regents Of The University Of California Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
WO2008077621A1 (de) * 2006-12-23 2008-07-03 Aplagen Gmbh Verfahren zur ausbildung von disulfidbrücken
EP2707018B1 (en) 2011-05-10 2015-11-04 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods and pharmaceutical compositions for the treatment of autoimmune diseases
GB201313352D0 (en) 2013-07-26 2013-09-11 Isis Innovation Identification of peptide ligands
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2016184784A1 (en) 2015-05-15 2016-11-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Peptides including binding domain of plasmodium falciparum proteins (cbp1 and cbp2) to chemokine cx3cl1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560521A (en) * 1967-08-07 1971-02-02 Merck & Co Inc Blocking groups for cysteine containing peptides
US3679655A (en) * 1968-06-28 1972-07-25 Hoechst Ag N,n-disubstituted aminoethylcarbamyl protecting groups for cysteine
DE1950711A1 (de) * 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
US3849388A (en) * 1968-10-15 1974-11-19 Ciba Geigy Corp Analogues of human thyrocalcitonin
GB1294771A (en) * 1969-01-31 1972-11-01 Sandoz Ltd Thyrocalcitonin derivative
CH523868A (de) * 1969-10-22 1972-06-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate
HU165733B (xx) * 1970-10-29 1974-10-28
ZA723287B (en) * 1971-06-18 1973-02-28 Hoffmann La Roche Nonapeptides and processes for the preparation thereof
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine

Also Published As

Publication number Publication date
IT1042496B (it) 1980-01-30
DE2540780C2 (xx) 1989-05-24
NL179909C (nl) 1986-12-01
JPS5833864B2 (ja) 1983-07-22
FR2284591B1 (xx) 1978-12-01
HU175202B (hu) 1980-06-28
SU849998A3 (ru) 1981-07-23
NL7510761A (nl) 1976-03-16
DK409775A (da) 1976-03-13
FR2284591A1 (fr) 1976-04-09
BE833336A (fr) 1975-12-31
YU39747B (en) 1985-04-30
AU8473775A (en) 1977-03-17
JPS5156448A (xx) 1976-05-18
ES440922A1 (es) 1977-06-16
DE2540780A1 (de) 1976-04-01
AU498757B2 (en) 1979-03-22
GB1527252A (en) 1978-10-04
YU230075A (en) 1982-02-28
US3929758A (en) 1975-12-30
CA1045117A (en) 1978-12-26

Similar Documents

Publication Publication Date Title
AU495920B2 (xx)
CS170674B1 (xx)
AU7138274A (xx)
AU7099174A (xx)
BG20443A1 (xx)
CH1107074A4 (xx)
AU481101A (xx)
AU481340A (xx)
AU481457A (xx)
AU481580A (xx)
AU482019A (xx)
AU482110A (xx)
AU482332A (xx)
AU481044A (xx)
AU480580A (xx)
AU480469A (xx)
BG19607A1 (xx)
BG19772A1 (xx)
BG19828A1 (xx)
BG19873A1 (xx)
BG20667A1 (xx)
BG19982A1 (xx)
BG20001A1 (xx)
BG20159A1 (xx)
CH588220A5 (xx)